Abstract
Mutations in SARS-CoV-2 have shown effective evasion of population immunity and increased affinity to the cellular receptor angiotensin-converting enzyme 2 (ACE2). However, in the dynamic environment of the respiratory tract, forces act on the binding partners, which raises the question of whether not only affinity but also force stability of the SARS-CoV-2–ACE2 interaction might be a selection factor for mutations. Using magnetic tweezers, we investigate the impact of amino acid substitutions in variants of concern (Alpha, Beta, Gamma and Delta) and on force-stability and bond kinetic of the receptor-binding domain–ACE2 interface at a single-molecule resolution. We find a higher affinity for all of the variants of concern (>fivefold) compared with the wild type. In contrast, Alpha is the only variant of concern that shows higher force stability (by 17%) compared with the wild type. Using molecular dynamics simulations, we rationalize the mechanistic molecular origins of this increase in force stability. Our study emphasizes the diversity of contributions to the transmissibility of variants and establishes force stability as one of the several factors for fitness. Understanding fitness advantages opens the possibility for the prediction of probable mutations, allowing a rapid adjustment of therapeutics, vaccines and intervention measures.
| Original language | English |
|---|---|
| Pages (from-to) | 399–405 |
| Number of pages | 7 |
| Journal | Nature Nanotechnology |
| Volume | 19 |
| Issue number | 3 |
| Early online date | 27 Nov 2023 |
| DOIs | |
| Publication status | Published - 2024 |
Bibliographical note
Publisher Copyright:© The Author(s), under exclusive licence to Springer Nature Limited 2023.
Funding
We thank M. Bos, J. de Graf and D. Dulin for helpful discussions and L. Schendel, N. Beier, B. Boeck, E. Durner, S. D. Pritzl and C. Koeroesy for help with experiments. This study was supported by German Research Foundation Projects 386143268 and 111166240, a Human Frontier Science Program Cross Disciplinary Fellowship (LT000395/2020C); European Molecular Biology Organization Non-Stipendiary long-term fellowship (ALTF 1047-2019) to L.F.M.; ERC Consolidator grant 'ProForce'; and the Physics Department of LMU Munich. R.C.B., P.S.F.C.G. and M.C.R.M. are supported by the National Science Foundation under grant MCB-2143787, by start-up funds provided by Auburn University, and R.C.B. additionally receives support from the National Institute of General Medical Sciences (NIGMS) of NIH through grant R24-GM145965.
| Funders | Funder number |
|---|---|
| European Molecular Biology Organization Non-Stipendiary | ALTF 1047-2019 |
| Physics Department of LMU Munich | |
| National Science Foundation | MCB-2143787 |
| National Institutes of Health | R24-GM145965 |
| National Institute of General Medical Sciences | |
| Auburn University | |
| European Research Council | |
| Human Frontier Science Program | |
| the Deutsche Forschungsgemeinschaft | 386143268, 111166240 |